AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor

Mise à jour : Il y a 4 ans
Référence : NCT00719524

Femme et Homme

Extrait

The purpose of this study is to determine the recommended dose of the combination of AVE8062 with platinum salts (cisplatin or carboplatin) and taxanes (docetaxel or paclitaxel) in patients with advanced solid tumors for which platinum-taxane doublet constitutes mainstay of care.


Critère d'inclusion

  • Neoplasms

Liens